VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
OTR Therapeutics' First-in-Class Oral Oncology Drug OTR-8100 Enters Clinical Trials Following $100M+ Financing
OTR Therapeutics' First-in-Class Oral Oncology Drug OTR-8100 Enters Clinical Trials Following $100M+ Financing
May 26, 2026 13:44 CST Updated 17:32
Share:
